跳至主要内容
临床试验/CTRI/2018/05/014203
CTRI/2018/05/014203招募中未知

A study to characterize the relation between pharmacokinetic parametersand clinical response to Colistin therapy in BMT patients

TRAC TMC Research Administrative Council0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients willing to give written informed consent.
  • Bone Marrow Transplantation patients being initiated on Colistin.
  • Neutropenic patients whose blood culture is showing sensitive to colistin (or)
  • Neutropenic patients not responding to Meropenem defined as hemodynamically
  • unstable or patients with persistent fever even after 24-48 hrs of start of
  • ECOG PS <= 2

排除标准

  • History of allergy to Colistin
  • Patients with active HIV infection or serology positive for HBV, HCV, HAV.
  • Any other medical condition or any abnormal lab findings which may adversely affect
  • the patient, based on physician discretion.

研究者

发起方
TRAC TMC Research Administrative Council

相似试验

Factors affecting the concentration of colistin in... | 临床试验